Aldesleukin (IL-2) is prescribed for a patient. The nurse reviews the patient’s medication list and would note a potential drug interaction if which drug class is also ordered?
Blog
Just before the second course of chemotherapy, the laborator…
Just before the second course of chemotherapy, the laboratory calls to report that the patient’s neutrophil count is 450 cells/mm3. The nurse expects that the oncologist will follow which course of treatment?
During a patient’s therapy with interleukins, the nurse moni…
During a patient’s therapy with interleukins, the nurse monitors the patient for capillary leak syndrome. Which assessment finding, if present, would indicate this problem?
What is the nurse’s priority intervention to reduce the risk…
What is the nurse’s priority intervention to reduce the risk of renal damage caused by cyclophosphamide?
A patient will be receiving aldesleukin (IL-2) (Proleukin),…
A patient will be receiving aldesleukin (IL-2) (Proleukin), 600,000 IU/kg every 8 hours for 14 doses. The patient weighs 220 pounds. Identify how many IU of medication this patient will receive per dose. _______
The nurse is assessing a patient who is receiving chemothera…
The nurse is assessing a patient who is receiving chemotherapy with an alkylating drug. Which assessment findings would be considered indications of an oncologic emergency? (Select all that apply.)
A client diagnosed with cancer is experiencing pain and the…
A client diagnosed with cancer is experiencing pain and the early signs of organ dysfunction. How should the nurse explain these signs and symptoms originate?
Cyclosporine is prescribed for a patient who had an organ tr…
Cyclosporine is prescribed for a patient who had an organ transplant. The nurse will monitor the patient for which common adverse effect?
What is the nurse’s priority action if extravasation of an a…
What is the nurse’s priority action if extravasation of an antineoplastic drug occurs during intravenous (IV) administration?
The nurse is developing a plan of care for a patient who is…
The nurse is developing a plan of care for a patient who is experiencing gastrointestinal adverse effects, including anorexia and nausea, after the first course of antineoplastic therapy. What is an appropriate outcome for this patient when dealing with this problem?